ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
83 717,73
-0,75%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) Actualités

VCYT

Veracyte (VCYT)

Veracyte Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VCYT
DateHeureSourceTitreSymboleSociété
10/03/202521h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
07/03/202522h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCYTVeracyte Inc
28/02/202503h58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCYTVeracyte Inc
24/02/202522h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
24/02/202522h05Business WireVeracyte Announces Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
19/02/202523h05Business WireVeracyte to Participate in Upcoming Investor ConferencesNASDAQ:VCYTVeracyte Inc
14/02/202514h30Business WireNew Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer ResearchNASDAQ:VCYTVeracyte Inc
12/02/202512h01Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VCYTVeracyte Inc
11/02/202514h30Business WireVeracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU SymposiumNASDAQ:VCYTVeracyte Inc
05/02/202514h30Business WireNew Study Shows Veracyte’s Decipher Bladder Test Predicts Disease Upstaging in Patients with Bladder CancerNASDAQ:VCYTVeracyte Inc
04/02/202522h30Business WireVeracyte to Release Fourth Quarter and Full-Year 2024 Financial Results on February 24, 2025NASDAQ:VCYTVeracyte Inc
05/12/202422h05Business WireVeracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesNASDAQ:VCYTVeracyte Inc
12/11/202415h30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VCYTVeracyte Inc
07/11/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCYTVeracyte Inc
06/11/202422h05Business WireVeracyte Announces Third Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
17/10/202400h43Business WireVeracyte to Release Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:VCYTVeracyte Inc
02/10/202414h20Business WireNew Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American MenNASDAQ:VCYTVeracyte Inc
15/09/202414h45Business WireNew Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate CancerNASDAQ:VCYTVeracyte Inc
04/09/202422h14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
04/09/202422h05Business WireVeracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of DirectorsNASDAQ:VCYTVeracyte Inc
26/08/202423h30Business WireVeracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:VCYTVeracyte Inc
26/08/202415h00Business WireVeracyte Named a Greater Bay Area Top Workplace by the San Francisco ChronicleNASDAQ:VCYTVeracyte Inc
06/08/202422h05Business WireVeracyte Announces Second Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
17/07/202423h00Business WireVeracyte to Release Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:VCYTVeracyte Inc
12/06/202422h57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCYTVeracyte Inc
03/06/202422h05Business WireVeracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid TumorsNASDAQ:VCYTVeracyte Inc
22/05/202422h05Business WireVeracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and CancerNASDAQ:VCYTVeracyte Inc
07/05/202422h05Business WireVeracyte Announces First Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
06/05/202422h05Business Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingNASDAQ:VCYTVeracyte Inc
22/04/202423h00Business WireVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:VCYTVeracyte Inc
 Showing the most relevant articles for your search:NASDAQ:VCYT

Dernières Valeurs Consultées

TG
A19YEQ
HSBC
BIT
UR9ZMY
UniCredit Bank
USOTC
DMFG
Decker Manufacturing (PK)
NASDAQ
BSCQ
Invesco BulletShares 202...
TG
A1ZL2J
Ferrovial Emisiones
USOTC
CMRZF
Commerce Resources (QB)
AQSE
GOOD.GB
Good Energy
NYSE
LEVI
Levi Strauss
TG
A280F4
Teva Pharmaceutical Fina...
COIN
BFCETH
Bifrost
TG
A19F23
Volkswagen Financial Ser...
LATK
COCNUSDT
Coca Network
BIT
UC8K3T
Unicredit Bank
TG
A2SANE
Temasek Financial I
BIT
UC5LUG
Unicredit Bank
BIT
UB9C37
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces